Evidence map›Paper›PMID 26743191›Full record

ArticleLung2016

Muscular Dysfunction in COPD: Systemic Effect or Deconditioning?

Eulogio Pleguezuelos, Cristina Esquinas, Eva Moreno, Lluis Guirao, Javier Ortiz, Joan Garcia-Alsina, Alex Merí, Marc Miravitlles

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Lung, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
  12. Exercise and Chronic Obstructive Pulmonary Disease (COPD).Advances in experimental medicine and biology · 2020
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.European respiratory review : an official journal of the European Respiratory Society · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eulogio PleguezuelosPhysical Medicine and Rehabilitation Department, Hospital Mataró, C/Cirera s/n 08302, Mataró, Barcelona, Spain. epleguezuelos@csdm.cat.
Cristina EsquinasPneumology Department, Hospital Universitari Vall d'Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
Eva MorenoPhysical Medicine and Rehabilitation Department, Hospitalet General Hospital, L´Hospitalet de Llobregat, Barcelona, Spain.
Lluis GuiraoPhysical Medicine and Rehabilitation Department, Hospital Mataró, C/Cirera s/n 08302, Mataró, Barcelona, Spain.
Javier OrtizBiomechanics Laboratory, INVALCOR, Barcelona, Spain.
Joan Garcia-AlsinaBiomechanics Laboratory, INVALCOR, Barcelona, Spain.
Alex MeríDepartment of Experimental Science and Healthcare, Faculty of Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Marc MiravitllesPneumology Department, Hospital Universitari Vall d'Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMuscular dysfunction has been described as one of the systemic manifestations of chronic obstructive pulmonary disease (COPD).

objectiveThe aim of this study was to evaluate muscular strength of the different anatomical compartments in patients with severe COPD compared with healthy controls.

methodWe performed a cross-sectional study in patients with severe COPD. We evaluated the muscular strength of the respiratory muscles, flexors and extensors of the cervical spine and knee, as well as handgrip force. The 6-min walking test (6MWT) and serum inflammatory markers were also analysed.

resultsTwenty-eight male patients with COPD (mean age 67.8 years, mean FEV1 (%) 39 %) and 24 male healthy controls (mean age 70.2 years) were studied. The strength of the flexors and extensors of the knee was significantly reduced in patients with COPD (p < 0.001 and p = 0.003). No differences were observed in the flexors and extensors of the cervical spine and handgrip force between groups. No correlation was observed between the muscular strength in the different anatomic compartments and the concentrations of blood inflammatory biomarkers or the metres walked in the 6MWT in COPD patients. However, a significant negative linear correlation was observed between the 6MWT and IL-6 and IL-8 levels (rho = -0.67, p = 0.001; rho = -0.57, p = 0.008). In addition, we found a negative correlation between the 6MWT and inspiratory capacity (rho = -0.755, p = 0.031).

conclusionsOur results suggest that muscular dysfunction in patients with COPD differs in different muscular compartments. The main factor for a reduced exercise capacity was a reduction in inspiratory capacity.

Indexed as

Muscle StrengthAgedBiomarkersCase-Control StudiesCross-Sectional StudiesExercise TestExercise ToleranceForced Expiratory VolumeHand StrengthHumansInflammation MediatorsInhalationIsometric ContractionLungMaleMiddle AgedBiomarkersInflammation MediatorsCOPDDeconditioningInflammatory markersMuscle function

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.